Learning Objectives:
• Learners will gain knowledge about the legal status of psilocybin in their regions, including regulatory frameworks and the ethical considerations surrounding its use, such as informed consent and patient autonomy.
• Learners will critically evaluate recent clinical studies and research findings that support the use of psilocybin in treating mental health disorders such as depression, anxiety, PTSD, and addiction, recognizing the strengths and limitations of this body of evidence.
• Learners will outline effective strategies for monitoring patient outcomes during and after psilocybin therapy, including recognizing adverse effects and assessing the long-term benefits of treatment.
• Learners will develop the skills necessary to determine patient eligibility for psilocybin treatment, understanding which conditions may benefit and identifying any contraindications or risk factors that must be considered.
Accreditation Statements:
VOCCME is co-sponsored by the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS), the Georgia Osteopathic Medical Association (GOMA), the Montana Osteopathic Medical Association (MOMA), the North Carolina Osteopathic Medical Association (NCOMA), the Ohio Osteopathic Association (OOA), the Osteopathic Physicians and Surgeons of Oregon (OPSO), and the Tennessee Osteopathic Medical Association (TOMA). Each of these osteopathic associations is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
The VOCCME has been designated for a maximum of 1 AOA Category 1-A credits by the VOC sponsors, who have authorized MAOPS to report CME and specialty credits to the AOA commensurate with the extent of the physician's participation in this activity.
MAOPS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MAOPS designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The VOCCME Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients relative to the content of these presentations.
AOA Grievance Policy:
All grievances should be in writing and specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial written response within 30 days of receipt. If a participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.